With 78.77% Distance From Low, Could Applied Dna Sciences Inc (NASDAQ:APDN) Post Further Gains?

EVTL

In recent trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 1.97 million shares changing hands at last check today with its beta currently measuring 0.46. Company’s recent per share price level of $1.46 trading at $0.26 or 21.63% at last check today assigns it a market valuation of $15.03M. That most recent trading price of APDN’s stock is at a discount of -1845.21% from its 52-week high price of $28.40 and is indicating a premium of 78.77% from its 52-week low price of $0.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 21.85 million shares which gives us an average trading volume of 9.43 million if we extend that period to 3-months.

For Applied Dna Sciences Inc (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.34 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Applied Dna Sciences Inc (NASDAQ:APDN) trade information

Upright in the green today for gaining 21.63%, in the last five days APDN remained trading in the red while hitting it’s week-highest on Thursday, 08/29/24 when the stock touched $1.46 price level, adding 44.59% to its value on the day. Applied Dna Sciences Inc’s shares saw a change of -88.17% in year-to-date performance and have moved -39.69% in past 5-day. Applied Dna Sciences Inc (NASDAQ:APDN) showed a performance of 264.90% in past 30-days. Number of shares sold short was 1.73 million shares which calculate 1.15 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a rise of 2.67% to its recent value today. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would drop -2.74% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2.74% for stock’s current value.

Applied Dna Sciences Inc (APDN) estimates and forecasts

Statistics highlight that Applied Dna Sciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -87.01% of value to its shares in past 6 months, showing an annual growth rate of 88.16% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -73.70% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 900k for the same. And 2 analysts are in estimates of company making revenue of 1.04M in the next quarter. Company posted 780k and 891k of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 45.52% during past 5 years.

Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders

Insiders are in possession of 3.04% of company’s total shares while institution are holding 2.16 percent of that, with stock having share float percentage of 2.22%. Investors also watch the number of corporate investors in a company very closely, which is 2.16% institutions for Applied Dna Sciences Inc that are currently holding shares of the company. MATHER GROUP, LLC. is the top institutional holder at APDN for having 700.0 shares of worth $287.0. And as of 2024-06-30, it was holding 0.0803 of the company’s outstanding shares.